A new allergy and asthma drug called RPL554 is scheduled to begin human testing. The medication, which drugmakers say has fewer side effects than other asthma and allergy drugs, works by inhibiting two enzymes that play a part in the diseases. When one enzyme is blocked, it helps keep the airways open. When the other is blocked, inflammation is controlled. Experts say that a single drug that could control the two conditions could potentially treat millions of seasonal allergy and asthma...
Read moreThis month, I'm going in for an arthroscopic knee procedure. I've had a few day surgeries and outpatient procedures and I always bring up... Read more »
Are we being hysterical? December 13, 2008, professor of medical sociology and attending physician, Dr. Nicholas A Christakis, published an... Read more »
In the past couple of years, saline nasal irrigations such as the NetiPot have swept the United States as an all natural treatment for... Read more »
When you have allergies, the best thing you can do for yourself is to avoid your triggers. But first, you have to find out what your... Read more »
No matter how hard you try, you cannot hide from springtime allergens. They are ubiquitous. You can run but you cannot hide. About... Read more »
The American Academy of Pediatrics says that children taking stimulants for attention-deficit/hyperactivity disorder do not need a heart test before... Read more »
For many people, spring means opening the windows to take in the sun and fresh air. But people with seasonal allergies can find themselves trying to... Read more »
Molds... yuck! A fungus -- that's disgusting, right? And what does mold have to do with nasal allergies and asthma? The answer to that question is,... Read more »
Pediatricians, general practitioners, internists, allergists and pulmonologists can all treat asthma and allergies. Allergists or immunologists are... Read more »
The U.S. Food and Drug Administration has decided there is no need for a second study to determine that the migraine drug Levadex is effective.... Read more »